Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

Concerns have been raised by senior doctors surrounding the misuse of weight-loss pens in the UK, with some patients ...

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

The success of GLP-1R-targeting drugs highlights their viability as a treatment approach. Currently, there are four ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

The Biden administration has announced a new proposal to include weight-loss drugs under Medicare and Medicaid programmes. While the plan will help more than seven million Americans struggling with ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

Prime Minister Justin Trudeau is set to meet with the country's premiers this afternoon, after they asked for an urgent ...

The Biden administration plans to require Medicare and Medicaid to offer coverage of weight loss medications for people seeking obesity treatment.The new rule, which was proposed by the administration ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

The Biden administration is proposing that Medicare and Medicaid pay for popular anti-obesity drugs for more Americans.